Update on vaginal micronised progesterone soft gel capsule for unexplained threatened miscarriage

Description

In this Product Explainer, Obstetrician and Gynaecologist Dr Hugh Porter explains the role of vaginal micronised progesterone, including the indication, safety profile, clinical trial background and guidelines for use for the treatment and management of threatened miscarriage (6 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Richard Bradlow

Dr Richard Bradlow

Alcohol Addiction Assessment and Advice

Prof Rodney Baber AM

Prof Rodney Baber AM

Premature Ovarian Insufficiency – The New Guidelines

Dr Sam Mehr

Dr Sam Mehr

Paediatric Allergic Rhinitis & Immunotherapy

Dr Andrew Scroop

Dr Andrew Scroop

Inhaler Devices

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Hugh Porter

expert

Dr Hugh Porter

Obstetrician and Gynaecologist

Date published: 23 September 2025